Our data suggested that improved blood glycemic control, such as decreased levels of fasting blood glucose, insulin and HbA1c, and increased glucose sensitivity following 24-week interventions, was significantly associated with improved DLCO in the patients with T2DM (Table 4). Here, INS is linked to type 2 diabetes mellitus.